Skip to content

Details

​Note: This is a NYC event. Please RSVP HERE: https://luma.com/638zvztn

BrainHealth innovation is difficult to scale. It scales when Founders, clinicians, investors, operators, and budget owners push each other to think bigger, reduce friction and demonstrate a quantifiiable ROI.

On Monday, June 22nd, 5:30pm, join an information-packed session in Midtown NYC focused on practical go-to-market best practices and real learnings from BrainHealth VCs. If you are building, investing in, or supporting BrainHealth innovation - this is the room for you.

Confirmed speakers (more to come):
Moderator: Richard Hatzfeld, Co-Lead, Global Health Impact, FINN Partners https://www.linkedin.com/in/richard-hatzfeld-9a61634
VC Panel:
a) Jeremy Sohn, Managing Partner, P74 Bio and P74 Ventures https://www.linkedin.com/in/jeremysohn/
b) Gal Noyman Veksler PhD, Partner, LionBird https://www.linkedin.com/in/gal-noyman-veksler-phd-4622b939
c) Dr. Maria Blekher, Managing Partner, Serendipity Impact VC https://www.linkedin.com/in/drmariablekher

​Go-To-Market Keynote: Esther Howard, CEO, Bezyl https://www.linkedin.com/in/esther-howard-7352b3b3/

Don't miss this chance to meet speakers / investors from Phoenix, Boston, Tokyo, Tel Aviv and Washington. Food and beverage will be provided. Save your spot for "BrainHealth at the Crossroads: Investment + GTM", Monday, June 22nd, 5:30pm at FINN Partners, 55th & Broadway.

RSVP: https://luma.com/638zvztn

You may also like